Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $4.03 Analyst target: $7.32 Upside: 81.64%
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that decodes biology by integrating technological innovations in biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company is headquartered in Salt Lake City, Utah.
See the full interactive analysis & chart →Informational only — not investment advice.